APO Research

APO RESEARCH · REPORT

Tumor MRD Detection Products and Services

Selected research

Industry Growth & Trends

Global Tumor MRD Detection Products and Services Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Tumor MRD Detection Products and Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tumor MRD Detection Products and Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tumor MRD Detection Products and Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tumor MRD Detection Products and Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Tumor MRD Detection Products and Services market include Natera, Guardant Health, SeraCare Life Sciences, Inc. (LGC), Adaptive Biotechnologies, Invitae(ArcherDX), Cergentis B.V., LexentBio(Foundation Medicine), Genecast and Genetron Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tumor MRD Detection Products and Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tumor MRD Detection Products and Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tumor MRD Detection Products and Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tumor MRD Detection Products and Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Tumor MRD Detection Products and Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tumor MRD Detection Products and Services Market by Company

Natera

Guardant Health

SeraCare Life Sciences, Inc. (LGC)

Adaptive Biotechnologies

Invitae(ArcherDX)

Cergentis B.V.

LexentBio(Foundation Medicine)

Genecast

Genetron Health

Acornmed

Shenzhen Neoimmune Co., Ltd.

Tung Tree Gene

Geneseeq

BGI Genomics

Burning Rock Biotech Limited

GenePlus

Tumor MRD Detection Products and Services Segment by Type

MRD Detection Products

In Vitro Diagnostic (IVD) Test Service

Tumor MRD Detection Products and Services Segment by Application

Lung Cancer

Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)

Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)

Urinary System Tumors (Bladder Cancer)

Central Nervous System Tumors

Soft Tissue and Bone Tumors

Thyroid Cancer and Melanoma

Tumor MRD Detection Products and Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor MRD Detection Products and Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor MRD Detection Products and Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor MRD Detection Products and Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Tumor MRD Detection Products and Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Tumor MRD Detection Products and Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Tumor MRD Detection Products and Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Tumor MRD Detection Products and Services Market Share by Region (2021-2026) Table 4. Global Tumor MRD Detection Products and Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Tumor MRD Detection Products and Services Market Share by Region (2027-2032) Table 6. Global Tumor MRD Detection Products and Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Tumor MRD Detection Products and Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Tumor MRD Detection Products and Services Market Size Share by Type (2021-2026) Table 9. Global Tumor MRD Detection Products and Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Tumor MRD Detection Products and Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Tumor MRD Detection Products and Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Tumor MRD Detection Products and Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Tumor MRD Detection Products and Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Tumor MRD Detection Products and Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Tumor MRD Detection Products and Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Tumor MRD Detection Products and Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Tumor MRD Detection Products and Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Tumor MRD Detection Products and Services Market Size Share by Application (2021-2026) Table 24. Global Tumor MRD Detection Products and Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Tumor MRD Detection Products and Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Tumor MRD Detection Products and Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Tumor MRD Detection Products and Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Tumor MRD Detection Products and Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Tumor MRD Detection Products and Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Tumor MRD Detection Products and Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Tumor MRD Detection Products and Services Industry Trends Table 37. Tumor MRD Detection Products and Services Industry Drivers Table 38. Tumor MRD Detection Products and Services Industry Opportunities and Challenges Table 39. Tumor MRD Detection Products and Services Industry Restraints Table 40. Global Tumor MRD Detection Products and Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Tumor MRD Detection Products and Services Revenue Market Share by Company (2021-2026) Table 42. Global Tumor MRD Detection Products and Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Tumor MRD Detection Products and Services Key Company Headquarters & Area Served Table 44. Global Tumor MRD Detection Products and Services Company, Product Type & Application Table 45. Global Tumor MRD Detection Products and Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Tumor MRD Detection Products and Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Natera Company Information Table 49. Natera Business Overview Table 50. Natera Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Natera Tumor MRD Detection Products and Services Product Portfolio Table 52. Natera Recent Development Table 53. Guardant Health Company Information Table 54. Guardant Health Business Overview Table 55. Guardant Health Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Guardant Health Tumor MRD Detection Products and Services Product Portfolio Table 57. Guardant Health Recent Development Table 58. SeraCare Life Sciences, Inc. (LGC) Company Information Table 59. SeraCare Life Sciences, Inc. (LGC) Business Overview Table 60. SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Product Portfolio Table 62. SeraCare Life Sciences, Inc. (LGC) Recent Development Table 63. Adaptive Biotechnologies Company Information Table 64. Adaptive Biotechnologies Business Overview Table 65. Adaptive Biotechnologies Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Adaptive Biotechnologies Tumor MRD Detection Products and Services Product Portfolio Table 67. Adaptive Biotechnologies Recent Development Table 68. Invitae(ArcherDX) Company Information Table 69. Invitae(ArcherDX) Business Overview Table 70. Invitae(ArcherDX) Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Invitae(ArcherDX) Tumor MRD Detection Products and Services Product Portfolio Table 72. Invitae(ArcherDX) Recent Development Table 73. Cergentis B.V. Company Information Table 74. Cergentis B.V. Business Overview Table 75. Cergentis B.V. Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Cergentis B.V. Tumor MRD Detection Products and Services Product Portfolio Table 77. Cergentis B.V. Recent Development Table 78. LexentBio(Foundation Medicine) Company Information Table 79. LexentBio(Foundation Medicine) Business Overview Table 80. LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Product Portfolio Table 82. LexentBio(Foundation Medicine) Recent Development Table 83. Genecast Company Information Table 84. Genecast Business Overview Table 85. Genecast Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Genecast Tumor MRD Detection Products and Services Product Portfolio Table 87. Genecast Recent Development Table 88. Genetron Health Company Information Table 89. Genetron Health Business Overview Table 90. Genetron Health Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Genetron Health Tumor MRD Detection Products and Services Product Portfolio Table 92. Genetron Health Recent Development Table 93. Acornmed Company Information Table 94. Acornmed Business Overview Table 95. Acornmed Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Acornmed Tumor MRD Detection Products and Services Product Portfolio Table 97. Acornmed Recent Development Table 98. Shenzhen Neoimmune Co., Ltd. Company Information Table 99. Shenzhen Neoimmune Co., Ltd. Business Overview Table 100. Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Product Portfolio Table 102. Shenzhen Neoimmune Co., Ltd. Recent Development Table 103. Tung Tree Gene Company Information Table 104. Tung Tree Gene Business Overview Table 105. Tung Tree Gene Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Tung Tree Gene Tumor MRD Detection Products and Services Product Portfolio Table 107. Tung Tree Gene Recent Development Table 108. Geneseeq Company Information Table 109. Geneseeq Business Overview Table 110. Geneseeq Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Geneseeq Tumor MRD Detection Products and Services Product Portfolio Table 112. Geneseeq Recent Development Table 113. BGI Genomics Company Information Table 114. BGI Genomics Business Overview Table 115. BGI Genomics Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. BGI Genomics Tumor MRD Detection Products and Services Product Portfolio Table 117. BGI Genomics Recent Development Table 118. Burning Rock Biotech Limited Company Information Table 119. Burning Rock Biotech Limited Business Overview Table 120. Burning Rock Biotech Limited Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Burning Rock Biotech Limited Tumor MRD Detection Products and Services Product Portfolio Table 122. Burning Rock Biotech Limited Recent Development Table 123. GenePlus Company Information Table 124. GenePlus Business Overview Table 125. GenePlus Tumor MRD Detection Products and Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. GenePlus Tumor MRD Detection Products and Services Product Portfolio Table 127. GenePlus Recent Development Table 128. North America Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Tumor MRD Detection Products and Services Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Tumor MRD Detection Products and Services Market Share by Country (2021-2026) Table 131. North America Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Tumor MRD Detection Products and Services Market Share Forecast by Country (2027-2032) Table 133. Europe Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Tumor MRD Detection Products and Services Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Tumor MRD Detection Products and Services Market Share by Country (2021-2026) Table 136. Europe Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Tumor MRD Detection Products and Services Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Tumor MRD Detection Products and Services Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Tumor MRD Detection Products and Services Market Share by Country (2021-2026) Table 141. Asia-Pacific Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Tumor MRD Detection Products and Services Market Share Forecast by Country (2027-2032) Table 143. Latin America Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Tumor MRD Detection Products and Services Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Tumor MRD Detection Products and Services Market Share by Country (2021-2026) Table 146. Latin America Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Tumor MRD Detection Products and Services Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Tumor MRD Detection Products and Services Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Tumor MRD Detection Products and Services Market Share by Country (2021-2026) Table 151. Middle East & Africa Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Tumor MRD Detection Products and Services Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Tumor MRD Detection Products and Services Product Image Figure 3. Global Tumor MRD Detection Products and Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Tumor MRD Detection Products and Services Market Share by Region: 2025 VS 2032 Figure 6. Global Tumor MRD Detection Products and Services Market Share by Region (2021-2032) Figure 7. North America Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. MRD Detection Products Image Figure 13. Global MRD Detection Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. In Vitro Diagnostic (IVD) Test Service Image Figure 15. Global In Vitro Diagnostic (IVD) Test Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Tumor MRD Detection Products and Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Tumor MRD Detection Products and Services Market Share by Type 2025 VS 2032 Figure 18. North America Tumor MRD Detection Products and Services Market Size Share by Type (2021-2032) Figure 19. Europe Tumor MRD Detection Products and Services Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Tumor MRD Detection Products and Services Market Size Share by Type (2021-2032) Figure 21. Latin America Tumor MRD Detection Products and Services Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Tumor MRD Detection Products and Services Market Size Share by Type (2021-2032) Figure 23. Lung Cancer Image Figure 24. Global Lung Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer) Image Figure 26. Global Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer) Image Figure 28. Global Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Urinary System Tumors (Bladder Cancer) Image Figure 30. Global Urinary System Tumors (Bladder Cancer) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Central Nervous System Tumors Image Figure 32. Global Central Nervous System Tumors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Soft Tissue and Bone Tumors Image Figure 34. Global Soft Tissue and Bone Tumors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Thyroid Cancer and Melanoma Image Figure 36. Global Thyroid Cancer and Melanoma Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Tumor MRD Detection Products and Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Tumor MRD Detection Products and Services Market Share by Application 2025 VS 2032 Figure 39. North America Tumor MRD Detection Products and Services Market Size Share by Application (2021-2032) Figure 40. Europe Tumor MRD Detection Products and Services Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Tumor MRD Detection Products and Services Market Size Share by Application (2021-2032) Figure 42. Latin America Tumor MRD Detection Products and Services Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Tumor MRD Detection Products and Services Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Tumor MRD Detection Products and Services Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Tumor MRD Detection Products and Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Tumor MRD Detection Products and Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Tumor MRD Detection Products and Services Market Share by Country (2021-2032) Figure 49. Europe Tumor MRD Detection Products and Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Tumor MRD Detection Products and Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Tumor MRD Detection Products and Services Market Share by Country (2021-2032) Figure 52. Asia-Pacific Tumor MRD Detection Products and Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Tumor MRD Detection Products and Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Tumor MRD Detection Products and Services Market Share by Country (2021-2032) Figure 55. Latin America Tumor MRD Detection Products and Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Tumor MRD Detection Products and Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Tumor MRD Detection Products and Services Market Share by Country (2021-2032) Figure 58. Middle East & Africa Tumor MRD Detection Products and Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Tumor MRD Detection Products and Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Tumor MRD Detection Products and Services Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • MRD Detection Products
  • In Vitro Diagnostic (IVD) Test Service
Applications
  • Lung Cancer
  • Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)
  • Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)
  • Urinary System Tumors (Bladder Cancer)
  • Central Nervous System Tumors
  • Soft Tissue and Bone Tumors
  • Thyroid Cancer and Melanoma
Companies covered
  • Natera
  • Guardant Health
  • SeraCare Life Sciences, Inc. (LGC)
  • Adaptive Biotechnologies
  • Invitae(ArcherDX)
  • Cergentis B.V.
  • LexentBio(Foundation Medicine)
  • Genecast
  • Genetron Health
  • Acornmed
  • Shenzhen Neoimmune Co., Ltd.
  • Tung Tree Gene
  • Geneseeq
  • BGI Genomics
  • Burning Rock Biotech Limited
  • GenePlus

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Tumor MRD Detection Products and Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Tumor MRD Detection Products and Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Tumor MRD Detection Products and Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Tumor MRD Detection Products and Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Tumor MRD Detection Products and Services Market Size (2021-2032)
  8. 1.5.1 North America Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032)
2 Tumor MRD Detection Products and Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 MRD Detection Products
  3. 2.1.2 In Vitro Diagnostic (IVD) Test Service
  4. 2.2 Global Tumor MRD Detection Products and Services Market Size by Type
  5. 2.2.1 Global Tumor MRD Detection Products and Services Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Tumor MRD Detection Products and Services Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Tumor MRD Detection Products and Services Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Tumor MRD Detection Products and Services Market Size by Regions
  9. 2.3.1 North America Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026)
3 Tumor MRD Detection Products and Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Lung Cancer
  3. 3.1.2 Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)
  4. 3.1.3 Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)
  5. 3.1.4 Urinary System Tumors (Bladder Cancer)
  6. 3.1.5 Central Nervous System Tumors
  7. 3.1.6 Soft Tissue and Bone Tumors
  8. 3.1.7 Thyroid Cancer and Melanoma
  9. 3.2 Global Tumor MRD Detection Products and Services Market Size by Application
  10. 3.2.1 Global Tumor MRD Detection Products and Services Market Size Overview by Application (2021-2032)
  11. 3.2.2 Global Tumor MRD Detection Products and Services Historic Market Size Review by Application (2021-2026)
  12. 3.2.3 Global Tumor MRD Detection Products and Services Market Size Forecasted by Application (2027-2032)
  13. 3.3 Global Tumor MRD Detection Products and Services Market Size by Regions
  14. 3.3.1 North America Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026)
  15. 3.3.2 Europe Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026)
  16. 3.3.3 Asia-Pacific Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026)
  17. 3.3.4 South America Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026)
  18. 3.3.5 Middle East and Africa Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Tumor MRD Detection Products and Services Industry Trends
  2. 4.2 Tumor MRD Detection Products and Services Industry Drivers
  3. 4.3 Tumor MRD Detection Products and Services Industry Opportunities and Challenges
  4. 4.4 Tumor MRD Detection Products and Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Tumor MRD Detection Products and Services Revenue (2021-2026)
  2. 5.2 Global Tumor MRD Detection Products and Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Tumor MRD Detection Products and Services Key Company Headquarters & Area Served
  4. 5.4 Global Tumor MRD Detection Products and Services Company, Product Type & Application
  5. 5.5 Global Tumor MRD Detection Products and Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Tumor MRD Detection Products and Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Tumor MRD Detection Products and Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Tumor MRD Detection Products and Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Natera
  2. 6.1.1 Natera Company Information
  3. 6.1.2 Natera Business Overview
  4. 6.1.3 Natera Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Natera Tumor MRD Detection Products and Services Product Portfolio
  6. 6.1.5 Natera Recent Developments
  7. 6.2 Guardant Health
  8. 6.2.1 Guardant Health Company Information
  9. 6.2.2 Guardant Health Business Overview
  10. 6.2.3 Guardant Health Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Guardant Health Tumor MRD Detection Products and Services Product Portfolio
  12. 6.2.5 Guardant Health Recent Developments
  13. 6.3 SeraCare Life Sciences, Inc. (LGC)
  14. 6.3.1 SeraCare Life Sciences, Inc. (LGC) Company Information
  15. 6.3.2 SeraCare Life Sciences, Inc. (LGC) Business Overview
  16. 6.3.3 SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Product Portfolio
  18. 6.3.5 SeraCare Life Sciences, Inc. (LGC) Recent Developments
  19. 6.4 Adaptive Biotechnologies
  20. 6.4.1 Adaptive Biotechnologies Company Information
  21. 6.4.2 Adaptive Biotechnologies Business Overview
  22. 6.4.3 Adaptive Biotechnologies Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Adaptive Biotechnologies Tumor MRD Detection Products and Services Product Portfolio
  24. 6.4.5 Adaptive Biotechnologies Recent Developments
  25. 6.5 Invitae(ArcherDX)
  26. 6.5.1 Invitae(ArcherDX) Company Information
  27. 6.5.2 Invitae(ArcherDX) Business Overview
  28. 6.5.3 Invitae(ArcherDX) Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Invitae(ArcherDX) Tumor MRD Detection Products and Services Product Portfolio
  30. 6.5.5 Invitae(ArcherDX) Recent Developments
  31. 6.6 Cergentis B.V.
  32. 6.6.1 Cergentis B.V. Company Information
  33. 6.6.2 Cergentis B.V. Business Overview
  34. 6.6.3 Cergentis B.V. Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Cergentis B.V. Tumor MRD Detection Products and Services Product Portfolio
  36. 6.6.5 Cergentis B.V. Recent Developments
  37. 6.7 LexentBio(Foundation Medicine)
  38. 6.7.1 LexentBio(Foundation Medicine) Company Information
  39. 6.7.2 LexentBio(Foundation Medicine) Business Overview
  40. 6.7.3 LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Product Portfolio
  42. 6.7.5 LexentBio(Foundation Medicine) Recent Developments
  43. 6.8 Genecast
  44. 6.8.1 Genecast Company Information
  45. 6.8.2 Genecast Business Overview
  46. 6.8.3 Genecast Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Genecast Tumor MRD Detection Products and Services Product Portfolio
  48. 6.8.5 Genecast Recent Developments
  49. 6.9 Genetron Health
  50. 6.9.1 Genetron Health Company Information
  51. 6.9.2 Genetron Health Business Overview
  52. 6.9.3 Genetron Health Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Genetron Health Tumor MRD Detection Products and Services Product Portfolio
  54. 6.9.5 Genetron Health Recent Developments
  55. 6.10 Acornmed
  56. 6.10.1 Acornmed Company Information
  57. 6.10.2 Acornmed Business Overview
  58. 6.10.3 Acornmed Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Acornmed Tumor MRD Detection Products and Services Product Portfolio
  60. 6.10.5 Acornmed Recent Developments
  61. 6.11 Shenzhen Neoimmune Co., Ltd.
  62. 6.11.1 Shenzhen Neoimmune Co., Ltd. Company Information
  63. 6.11.2 Shenzhen Neoimmune Co., Ltd. Business Overview
  64. 6.11.3 Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Product Portfolio
  66. 6.11.5 Shenzhen Neoimmune Co., Ltd. Recent Developments
  67. 6.12 Tung Tree Gene
  68. 6.12.1 Tung Tree Gene Company Information
  69. 6.12.2 Tung Tree Gene Business Overview
  70. 6.12.3 Tung Tree Gene Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Tung Tree Gene Tumor MRD Detection Products and Services Product Portfolio
  72. 6.12.5 Tung Tree Gene Recent Developments
  73. 6.13 Geneseeq
  74. 6.13.1 Geneseeq Company Information
  75. 6.13.2 Geneseeq Business Overview
  76. 6.13.3 Geneseeq Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Geneseeq Tumor MRD Detection Products and Services Product Portfolio
  78. 6.13.5 Geneseeq Recent Developments
  79. 6.14 BGI Genomics
  80. 6.14.1 BGI Genomics Company Information
  81. 6.14.2 BGI Genomics Business Overview
  82. 6.14.3 BGI Genomics Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 BGI Genomics Tumor MRD Detection Products and Services Product Portfolio
  84. 6.14.5 BGI Genomics Recent Developments
  85. 6.15 Burning Rock Biotech Limited
  86. 6.15.1 Burning Rock Biotech Limited Company Information
  87. 6.15.2 Burning Rock Biotech Limited Business Overview
  88. 6.15.3 Burning Rock Biotech Limited Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Burning Rock Biotech Limited Tumor MRD Detection Products and Services Product Portfolio
  90. 6.15.5 Burning Rock Biotech Limited Recent Developments
  91. 6.16 GenePlus
  92. 6.16.1 GenePlus Company Information
  93. 6.16.2 GenePlus Business Overview
  94. 6.16.3 GenePlus Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 GenePlus Tumor MRD Detection Products and Services Product Portfolio
  96. 6.16.5 GenePlus Recent Developments
7 North America
  1. 7.1 North America Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
  3. 7.3 North America Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
  3. 8.3 Europe Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
  3. 10.3 South America Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research